BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao W, Chen X, Chi W, Xue M. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression. Int J Mol Med 2020;46:1743-54. [PMID: 33000222 DOI: 10.3892/ijmm.2020.4722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Jin C, Li R, Deng T, Li J, Yang Y, Li H, Chen K, Xiong H, Chen G, Wang Y. Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:784553. [PMID: 34988119 DOI: 10.3389/fmolb.2021.784553] [Reference Citation Analysis]
2 Fang C, Liu S, Feng K, Huang C, Zhang Y, Wang J, Lin H, Wang J, Zhong C. Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. Sci Rep 2022;12:6642. [PMID: 35459272 DOI: 10.1038/s41598-022-10508-1] [Reference Citation Analysis]
3 Zhang Z, Xia F, Xu Z, Peng J, Kang F, Li J, Zhang W, Hong Q. Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma. Sci Rep 2022;12:8886. [PMID: 35614201 DOI: 10.1038/s41598-022-13046-y] [Reference Citation Analysis]
4 Wu ZH, Li ZW, Yang DL, Liu J. Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:713925. [PMID: 34869306 DOI: 10.3389/fcell.2021.713925] [Reference Citation Analysis]
5 Zhang Z, Shang J, Hu B, Shi H, Cao Y, Li J, Jiao T, Zhang W, Lu S. Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature. Front Immunol 2022;13:836576. [DOI: 10.3389/fimmu.2022.836576] [Reference Citation Analysis]
6 Zhu XL, Li Q, Shen J, Shan L, Zuo ED, Cheng X. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database. Transl Cancer Res 2021;10:5337-51. [PMID: 35116381 DOI: 10.21037/tcr-21-2440] [Reference Citation Analysis]
7 Zhang Z, Zhang W, Wang Y, Wan T, Hu B, Li C, Ge X, Lu S. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:792676. [PMID: 35295858 DOI: 10.3389/fcell.2022.792676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Feng Y, Hu X, Ma K, Zhang B, Sun C. Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma. Biomed Res Int 2021;2021:6640652. [PMID: 34095306 DOI: 10.1155/2021/6640652] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Liu ZK, Wu KF, Zhang RY, Kong LM, Shang RZ, Lv JJ, Li C, Lu M, Yong YL, Zhang C, Zheng NS, Li YH, Chen ZN, Bian H, Wei D. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma. Front Oncol 2022;12:794034. [PMID: 35311105 DOI: 10.3389/fonc.2022.794034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tang P, Qu W, Wang T, Liu M, Wu D, Tan L, Zhou H. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma. Front Genet 2021;12:785185. [DOI: 10.3389/fgene.2021.785185] [Reference Citation Analysis]